Search SAMHSA Publications and Digital Products
Store Facets Summary
- Clear all filters
- Remove Professional Care Providers
- Remove Public Health Professionals
- Remove People with Substance Use or Abuse Problems as Audience
- Remove Guidelines or Manual
- Remove People with Substance Use or Abuse Problems as Population Group
- Remove Mature Adults as Population Group
- Remove Heroin
- Remove Marijuana
- Remove Pain Relievers
- Remove Medication-Assisted Treatment
- Remove Naltrexone
- Remove Cognitive Behavioral Therapy
- Remove Motivational Interventions
- Remove Treatment Planning
Main page content
Published: August 2021
The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Published: July 2021
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
Published: December 2019
This guide supports health care providers, systems, and communities seeking to prevent marijuana use by pregnant women. It describes relevant research findings, examines emerging and best practices, identifies knowledge gaps and implementation challenges, and offers useful resources.